×

Stereotaxis to Report Third Quarter 2014 Financial Results on November 5, 2014

ST. LOUIS, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it will release financial results for its 2014 third quarter ended September 30, 2014 on Wednesday, November 5, 2014 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company's results and corporate developments.

What: Stereotaxis third quarter 2014 financial results conference call
When: Wednesday, November 5th at 4:30 p.m. Eastern Time (1:30 p.m. PT)
Dial In Number: To access the live call, dial 888-299-7209 (US and Canada) or 719-325-2491 (International) and give the participant pass code 6353523.
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis' website at www.stereotaxis.com
Call Replay: A replay of the call will be available approximately one hour following the end of the call through 11:59 p.m. ET on Wednesday, November 12, 2014.
Replay Numbers: 888-203-1112 (US and Canada)
719-457-0820 (International)
Replay passcode: 6353523

About Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems and the Vdrive™ robotic navigation system and consumables.

The core components of Stereotaxis systems have received regulatory clearance in the U.S., European Union, Canada, China, Japan and elsewhere. The V-Sono™ ICE catheter manipulator and V-Loop™ variable loop catheter manipulator have received U.S. clearance, and the V-CAS™ catheter advancement system has been submitted for review by the U.S. Food and Drug Administration. For more information, please visit www.stereotaxis.com.

CONTACT: Company Contact: Marty Stammer Chief Financial Officer 314-678-6155 Investor Contact: Todd Kehrli / Jim Byers MKR Group, Inc. 323-468-2300 stxs@mkr-group.com

Source:Stereotaxis, Inc.